|
|
 |
|
|
|
 |
|
|
|
|
|||||||||||||||||
Independent Reviewer
Target Audience This activity is intended for medical oncologists, hematologist-oncologists, urologists, pathologists, and allied health care professionals caring for patients with renal cell carcinoma. Prerequisites There are no prerequisites. Statement of Need Given the availability of multiple treatment options, several questions emerge about how to incorporate these new therapies into the management of metastatic renal cell carcinoma (RCC): Is there an optimal agent, sequence, or combination of therapies? Is there a role for cytokine therapy in the current treatment paradigm for RCC? Are these agents active in nonclear cell RCC? Most importantly, can cure rates be improved with use of these agents earlier in the disease (neoadjuvant or adjuvant therapy)? Ongoing and planned clinical trials hope to provide insight into many of these questions. This educational initiative will provide medical oncologists, hematologist-oncologists, urologists, pathologists, and allied healthcare professionals caring for patients with renal cell carcinoma the opportunity to learn the most recent advances in the treatment of renal cell carcinoma. Objectives After completing this activity, you should be able to:
Method of Participation This Internet-based activity takes approximately 2 hours to complete. You should review the objectives and cases, answer the multiple-choice posttest, and complete an evaluation form online. Once completed, you will be able to save your certificate to your own computer and print it on your own printer. Disclosure StatementAs a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is MedCases policy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The following was reported:
Notice of Off-Label Use Presentations In accordance with US Food and Drug Administration (FDA) requirements regarding the disclosure of off-label, investigational, or unapproved recommendations for the use of drugs or devices, you are advised that content in this activity contains reference(s) to uses of drugs or devices that are off-label, investigational, or unapproved in the United States. The following information is provided for educational purposes and not to endorse off-label use.
Disclaimer The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of MedCases’ name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients. All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have. The MedCases Web site does not define a standard of care, nor is it intended to dictate an exclusive course of management. Cases are provided for informational and educational purposes only and are not intended as medical advice. This information should not substitute for a visit or consultation with a health care provider. Privacy Statement MedCases is committed to maintaining site visitors rights to privacy and confidentiality of personal information. Personal information about site visitors, specific visitor's access and navigation, and information volunteered by site visitors, such as survey information and site registration information, may be used by MedCases to improve the site but will not be shared with or sold to other organizations for commercial purposes without the site visitor's express permission. Copyright Information Copyright © 2009 MedCases, LLC. All rights reserved. For Further Information MedCases
Hardware/Software Requirements and Technical AssistanceThis Web-based CME activity is best experienced using a current generation browser, such as Internet Explorer 5.5 or higher. This Web site requires that JavaScript and session cookies be enabled. In addition, you will require the Adobe Flash Player plugin to view the case simulation. Detailed Requirements:
More information about the software described above is available at the links below: If you need assistance, please email us at info@medcases.com. ConfirmationEnter your details in the box below and then click the Start Case button to begin. You may discontinue the case simulation at any time and then return later to resume where you left off. By clicking the Start Case button below, you are confirming that you have reviewed all the disclosures and important information. |
|||||||||||||||||||
|
